CXCR5 and systemic lupus erythematosus: Li, et al. discovered that CXCL13 could enhance the proliferation of human mesenchymal stem cells through the MAPK pathway [16], while Da, et al. found that CXCL13 enhanced mesangial cell growth via combination with CXCR5 in SLE [17].